AstraZeneca Accused of Cherry-Picking Vaccine Study Data

WASHINGTON (AP) — AstraZeneca may have included “outdated information” in touting the effectiveness of its COVID-19 vaccine in a U.S. study, federal health officials said Tuesday in an unusual public rift that could further erode confidence in the shot. In response, AstraZeneca said that it is working on more up-to-date information and that the more recent findings are consistent with its initial announcement that the vaccine offered strong protection.
Read more...

;